BETA

Beta Drugs Share PriceBeta Drugs

₹772.05
5.7 (0.74%)
As on 05 June, 2023 | 16:37 BSE: 531481 NSE: BETA

Beta Drugs Performance

Day Range

  • Low
  • High
772.05

52 Week Range

  • Low
  • High
772.05
  • Open Price
  • Previous Close
  • Volume

Start SIP in Beta Drugs

Start SIP

Beta Drugs Share Price

  • Over 1 Month -2.18%
  • Over 3 Month 15.23%
  • Over 6 Month 7.23%
  • Over 1 Year -9.19%

Beta Drugs Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 742
Price to Book Ratio
EPS 19.6
Dividend 0
Relative Strength Index 56.42
Money Flow Index 51.87
MACD Signal 5.56
Average True Range 29.07

Beta Drugs Investment Rating

  • Master Rating:
  • Beta Drugs has an operating revenue of Rs. 456.69 Cr. on a trailing 12-month basis. An annual revenue growth of 58% is outstanding, Pre-tax margin of 19% is great, ROE of 26% is exceptional. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 6% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 53 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Beta Drugs Financials
Indicator
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr

Beta Drugs Technicals

EMA & SMA

Current Price
₹772.05
5.7 (0.74%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹749.14
  • 50 Day
  • ₹729.9
  • 100 Day
  • ₹713.24
  • 200 Day
  • ₹700.41
  • 20 Day
  • ₹747.4
  • 50 Day
  • ₹724.31
  • 100 Day
  • ₹687.84
  • 200 Day
  • ₹716.82

Beta Drugs Resistance and Support

PIVOT
₹759.29
Resistance
First Resistance ₹773.47
Second Resistance ₹780.59
Third Resistance ₹794.77
RSI 56.42
MFI 51.87
MACD Single Line 5.56
MACD 5.37
Support
First Resistance ₹752.17
Second Resistance ₹737.99
Third Resistance ₹730.87

Beta Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,800 319,998 84.21
Week 3,920 307,994 78.57
1 Month 3,973 323,618 81.46
6 Month 3,104 243,917 78.58

Beta Drugs Result Highlights

Beta Drugs Synopsis

NSE-Medical-Diversified

Beta Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 124.85 Cr. and Equity Capital is Rs. 9.61 Cr. for the Year ended 31/03/2022. Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969.
Market Cap 742
Sales 125
Shares in Float 0.32
No of funds 2
Yield
Book Value 9.51
U/D Vol ratio 1.3
LTDebt / Equity 7
Alpha -0.08
Beta 0.49

Beta Drugs

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 66.73%66.71%66.71%66.71%
Foreign Portfolio Investors 0.29%0.29%0.29%0.29%
Individual Investors 22.52%22.6%22.61%
Others 10.46%10.4%10.39%33%

Beta Drugs Management

Name Designation
Mr. Rahul Batra Chairman & Managing Director
Mr. Varun Batra Joint Managing Director
Mr. Balwant Singh Whole Time Director
Mrs. Seema Chopra Whole Time Director
Mr. Ashutosh Shukla Whole Time Director
Mr. Manmohan Khanna Independent Director
Mr. Rohit Parti Independent Director

Beta Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Beta Drugs Corporate Action

Date Purpose Remarks
2023-05-08 Audited Results
2022-10-27 Quarterly Results
2022-04-27 Audited Results
2021-10-25 Quarterly Results
2021-04-27 Audited Results

Beta Drugs FAQs

What is Share Price of Beta Drugs ?

Beta Drugs share price is ₹772 As on 05 June, 2023 | 16:23

What is the Market Cap of Beta Drugs ?

The Market Cap of Beta Drugs is ₹742.2 Cr As on 05 June, 2023 | 16:23

What is the P/E ratio of Beta Drugs ?

The P/E ratio of Beta Drugs is As on 05 June, 2023 | 16:23

What is the PB ratio of Beta Drugs ?

The PB ratio of Beta Drugs is As on 05 June, 2023 | 16:23

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number